Prosecution Insights
Last updated: April 19, 2026

Shenzhen Turier Biotech Co. Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18027872 GLP-1R/GCGR Dual Target Agonist Polypeptide Derivative for Treatment of Hepatic Fibrosis Associated with Viral Hepatitis BRADLEY, CHRISTINA 1654 Final Rejection Mar 22, 2023
17801465 Polypeptide Compounds and Use Thereof in the Prevention or Treatment of Diabetes or Diabetic Complications BEANE, RANDALL L 1654 Final Rejection Sep 02, 2022

Managing Shenzhen Turier Biotech Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month